Literature DB >> 2719667

Solubilization and reconstitution of kidney 25-hydroxyvitamin D3 1 alpha- and 24-hydroxylases from vitamin D-replete pigs.

R W Gray1, J G Ghazarian.   

Abstract

Pig kidney mitochondrial 25-hydroxyvitamin D3 1 alpha- and 24-hydroxylase activities have been solubilized with cholate/Emulgen 911 and reconstituted with NADPH, ferredoxin reductase and ferredoxin. All three of these components are required for full catalytic activity of both enzymes. Both products were identified by co-chromatography with authentic metabolites on both normal and reverse-phase h.p.l.c. using solvent systems which were shown to separate 10-oxo-19-nor-25-hydroxyvitamin D3 from 1,25-dihydroxyvitamin D3 [1,25-(OH)2-D3]. In addition, periodate treatment of the 24,25-(OH)2-D3 product resulted in complete loss of the product as measured by protein-binding assay. Further purification by p-chloroamphetamine-Sepharose chromatography of a solubilized extract from a pig fed a normal diet increased the specific content of the cytochrome P-450 from 0.019 to 0.239 nmol/mg and the 1 alpha-hydroxylase activity from 4.75 to 268 pmol/h per mg. Activity of the 24-hydroxylase in the crude solubilized extract was 6.3 pmol/h per mg, but was undetectable after partial purification by a p-chloroamphetamine-Sepharose column. However, further fractionation of this material by DEAE-Sepharose chromatography resulted in a further increase in 1 alpha-hydroxylase activity to 430 pmol/h per mg and detection of 24-hydroxylase in a separate fraction at a level of 53 pmol/h per mg. Production of 1,25-(OH)2-D3 was linear with time up to 2 h and was dependent upon ferredoxin concentration as well as cytochrome P-450 concentration in the range of 0-40 nM. In the presence of excess ferredoxin and adequate amounts of cytochrome P-450, 1,25-(OH)2-D3 production was also dependent upon substrate concentrations in the range of 0.25 to 2.5 microM yielding an estimated Km of 1 microM. In the presence of excess substrate and ferredoxin, the catalytic-centre activity of the enzyme was estimated to be 1 h-1.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2719667      PMCID: PMC1138545          DOI: 10.1042/bj2590561

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  25 in total

1.  THE CARBON MONOXIDE-BINDING PIGMENT OF LIVER MICROSOMES. I. EVIDENCE FOR ITS HEMOPROTEIN NATURE.

Authors:  T OMURA; R SATO
Journal:  J Biol Chem       Date:  1964-07       Impact factor: 5.157

2.  Modulation of 25-hydroxyvitamin D3-24-hydroxylase by aminophylline: a cytochrome P-450 monooxygenase system.

Authors:  J A Kulkowski; T Chan; J Martinez; J G Ghazarian
Journal:  Biochem Biophys Res Commun       Date:  1979-09-12       Impact factor: 3.575

3.  The simultaneous measurement of vitamin D metabolites in plasma: studies in healthy adults and in patients with calcium nephrolithiasis.

Authors:  A E Caldas; R W Gray; J Lemann
Journal:  J Lab Clin Med       Date:  1978-05

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

5.  Mechanism of 25-hydroxyvitamin D3 24-hydroxylation: incorporation of oxygen-18 into the 24 position of 25-hydroxyvitamin D3.

Authors:  T C Madhok; H K Schnoes; H F DeLuca
Journal:  Biochemistry       Date:  1977-05-17       Impact factor: 3.162

6.  Reductive titrations of iron-sulfur proteins containing two to four iron atoms.

Authors:  W H Orme-Johnson; H Beinert
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

7.  Isolation of chick renal mitochondrial ferredoxin active in the 25-hydroxyvitamin D3-1alpha-hydroxylase system.

Authors:  J I Pedersen; J G Ghazarian; N R Orme-Johnson; H F DeLuca
Journal:  J Biol Chem       Date:  1976-07-10       Impact factor: 5.157

Review 8.  Recent advances in the metabolism of vitamin D.

Authors:  H F DeLuca
Journal:  Annu Rev Physiol       Date:  1981       Impact factor: 19.318

9.  Kinetic behavior of 25-hydroxyvitamin D-1-hydroxylase and -24-hydroxylase in rat kidney mitochondria.

Authors:  R Vieth; D Fraser
Journal:  J Biol Chem       Date:  1979-12-25       Impact factor: 5.157

10.  On the structure of putidaredoxin and cytochrome P-450 cam and their mode of interaction.

Authors:  K Dus
Journal:  Adv Exp Med Biol       Date:  1975       Impact factor: 2.622

View more
  6 in total

1.  Antigenic and catalytic disparity in the distribution of cytochrome P-450-dependent 25-hydroxyvitamin D3-1 alpha- and 24-hydroxylases.

Authors:  K Takezawa; B Moorthy; M L Mandel; J C Garancis; J G Ghazarian
Journal:  Histochemistry       Date:  1990

2.  25-Hydroxyvitamin D3-1 alpha-hydroxylase in porcine hepatic tissue: subcellular localization to both mitochondria and microsomes.

Authors:  B W Hollis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

3.  Characterization of mitochondrial cytochromes P-450 from pig kidney and liver catalysing 26-hydroxylation of 25-hydroxyvitamin D3 and C27 steroids.

Authors:  T Bergman; H Postlind
Journal:  Biochem J       Date:  1991-06-01       Impact factor: 3.857

4.  Reciprocal post-translational regulation of renal 1 alpha- and 24-hydroxylases of 25-hydroxyvitamin D3 by phosphorylation of ferredoxin. mRNA-directed cell-free synthesis and immunoisolation of ferredoxin.

Authors:  M L Mandel; B Moorthy; J G Ghazarian
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

5.  Liver mitochondrial cytochrome P450 CYP27 and recombinant-expressed human CYP27 catalyze 1 alpha-hydroxylation of 25-hydroxyvitamin D3.

Authors:  E Axén; H Postlind; H Sjöberg; K Wikvall
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

6.  Measurement of vitamin D3 metabolites in smelter workers exposed to lead and cadmium.

Authors:  S R Chalkley; J Richmond; D Barltrop
Journal:  Occup Environ Med       Date:  1998-07       Impact factor: 4.402

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.